Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gallbladder Neoplasms × Observation × Clear all

Status

Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6 Colorectal Neoplasms 6 Breast Neoplasms 5 Lung Neoplasms 4 Endometrial Neoplasms 4 Stomach Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Obesity 2 Meningioma 2 Lymphoma, Large B-Cell, Diffuse 2 Esophageal Neoplasms 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pseudomyxoma Peritonei 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Paranasal Sinus Neoplasms 1 Ovarian Neoplasms 1

Interventions

Gemcitabine 5 Cisplatin 5 Oxaliplatin 4 pembrolizumab 3 durvalumab 3 130-nm albumin-bound paclitaxel 3 Leucovorin 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 sintilimab 1 anlotinib 1 Trastuzumab 1 Taxes 1 Standard of Care 1 Platinum 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 Folfox protocol 1 Fluorouracil 1 Everolimus 1 Drug Therapy 1 Cholangiopancreatography, Endoscopic Retrograde 1 Biopsy 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06192719 2026-02-18

EULAT

Centre Paul Strauss

15,000 enrolled

Gastrointestinal

Cholelithiasis, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡